[go: up one dir, main page]

NO20024325D0 - Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use - Google Patents

Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use

Info

Publication number
NO20024325D0
NO20024325D0 NO20024325A NO20024325A NO20024325D0 NO 20024325 D0 NO20024325 D0 NO 20024325D0 NO 20024325 A NO20024325 A NO 20024325A NO 20024325 A NO20024325 A NO 20024325A NO 20024325 D0 NO20024325 D0 NO 20024325D0
Authority
NO
Norway
Prior art keywords
diagnostic
therapeutic use
envelope proteins
virus envelope
purified hepatitis
Prior art date
Application number
NO20024325A
Other languages
Norwegian (no)
Other versions
NO20024325L (en
Inventor
Geert Maertens
Fons Bosman
Marie-Ange Buyse
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of NO20024325D0 publication Critical patent/NO20024325D0/en
Publication of NO20024325L publication Critical patent/NO20024325L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20024325A 2001-01-11 2002-09-10 Purified hepatitis C virus envelope proteins for diagnosis and therapeutic use NO20024325L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26066901P 2001-01-11 2001-01-11
US31576801P 2001-08-30 2001-08-30
PCT/EP2002/000219 WO2002055548A2 (en) 2001-01-11 2002-01-11 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use

Publications (2)

Publication Number Publication Date
NO20024325D0 true NO20024325D0 (en) 2002-09-10
NO20024325L NO20024325L (en) 2002-11-11

Family

ID=26948130

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024325A NO20024325L (en) 2001-01-11 2002-09-10 Purified hepatitis C virus envelope proteins for diagnosis and therapeutic use

Country Status (16)

Country Link
EP (1) EP1463753A2 (en)
KR (1) KR20020089371A (en)
CN (1) CN1547588A (en)
AR (1) AR032240A1 (en)
AU (1) AU2002238502B2 (en)
BR (1) BR0203518A (en)
CA (1) CA2400643A1 (en)
CZ (1) CZ20032164A3 (en)
HU (1) HUP0302416A2 (en)
IL (1) IL151033A0 (en)
MX (1) MXPA02008886A (en)
NO (1) NO20024325L (en)
PL (1) PL363175A1 (en)
RU (1) RU2313363C2 (en)
TR (1) TR200202169T1 (en)
WO (1) WO2002055548A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03009626A (en) 2001-04-24 2004-06-30 Innogenetics Nv Constructs and methods for expression of recombinant hcv envelope proteins.
WO2004041853A2 (en) * 2002-11-08 2004-05-21 Innogenetics N.V. Hcv vaccine compositions comprising e1 and ns3 peptides
EP1561470A1 (en) * 2003-06-20 2005-08-10 Innogenetics N.V. HCV vaccines comprising the envelope-1 (E1) protein or the corresponding DNA and at least one antiviral agent
JP4342519B2 (en) * 2003-09-22 2009-10-14 株式会社グリーンペプタイド Hepatitis C virus-derived peptide
CN100365124C (en) * 2005-10-27 2008-01-30 云南大学 Determination and application of hepatitis C virus specific cDNA sequence
CN115980352A (en) * 2022-12-30 2023-04-18 宁波博肽生物技术有限公司 A kind of HCV antigen coating pretreatment agent, antigen coating method and detection kit

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1845108A3 (en) * 1994-07-29 2007-10-24 Innogenetics N.V. Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use

Also Published As

Publication number Publication date
AU2002238502B2 (en) 2007-09-06
CA2400643A1 (en) 2002-07-18
MXPA02008886A (en) 2003-04-25
TR200202169T1 (en) 2004-06-21
RU2002121632A (en) 2004-03-20
AR032240A1 (en) 2003-10-29
KR20020089371A (en) 2002-11-29
WO2002055548A3 (en) 2004-08-05
NO20024325L (en) 2002-11-11
WO2002055548A8 (en) 2002-10-31
CN1547588A (en) 2004-11-17
RU2313363C2 (en) 2007-12-27
AU2002238502A1 (en) 2002-07-24
CZ20032164A3 (en) 2003-10-15
IL151033A0 (en) 2003-04-10
HUP0302416A2 (en) 2003-10-28
EP1463753A2 (en) 2004-10-06
AU2002238502B9 (en) 2002-07-24
WO2002055548A2 (en) 2002-07-18
BR0203518A (en) 2002-12-17
PL363175A1 (en) 2004-11-15

Similar Documents

Publication Publication Date Title
DK1414471T3 (en) Therapeutic agents comprising pro-apoptotic proteins
NO20044192L (en) 17alpha-alkyl-17beta-oxy-ostratrienes and pharmaceutical preparations
LU91328I2 (en) Human papillomavirus vaccine Ätypes 6,11,16,18Ü (recombinant, adsorbed)
NO20030832L (en) Condensed cyclic compounds and their medical use
ATE315938T1 (en) 4'-SUBSTITUTED NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS C VIRUS-MEDIATED DISEASES
DK1054955T3 (en) Compositions comprising viruses and methods for concentrating virus preparations
NO20033556D0 (en) Pharmaceutical preparations
ATE275631T1 (en) RECOMBINANT VENEZOLAN EQUINE EQUINO CEPHALITIS VIRUS VACCINE
DE60237823D1 (en) MEDICAL TREATMENT INSTRUMENT
EP1307130A4 (en) VACCINE AGAINST HUMAN IMMUNE WEAK VIRUS
DE50209220D1 (en) Medical forceps
IL162236A0 (en) Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use
IS7830A (en) Hepatitis C virus (HCV) vaccine
NO20040249L (en) Blood group antigen fusion polypeptides and methods for their use
DE60008906D1 (en) MEDICAL PLIERS
DK1417189T3 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
DK1265577T3 (en) Medical or dental medical treatment chair
NO20033506D0 (en) Parasite-killing preparations and methods of use
NO20033829L (en) Virus killing preparations
EP1425039A4 (en) IMMUNOREACTIVE PEPTIDES OF HUMAN PAPILLOMAVIRUS
IS5777A (en) Vaccine hepatitis B virus variants and its use
NO20024325D0 (en) Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
ATE437656T1 (en) VACCINE AGAINST FORAL ACID VIRUS
NO20033120D0 (en) 2-arylimino-2,3-dihydrotiazole derivatives, processes for their preparation and therapeutic use thereof
ATA3922001A (en) MEDICAL ELECTRODE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application